Lack of cross-reactivity to meropenem in a patient with an allergy to imipenem-cilastatin.
Bauer
Seth L
SL
Wall
Geoffrey C
GC
Skoglund
Krissa J
KJ
Peters
Lisa K
LK
D000328:Adult; D015377:Cilastatin / Q000009:adverse effects* / Q000276:immunology; D000077728:Cilastatin, Imipenem Drug Combination; D003429:Cross Reactions / Q000276:immunology*; D004338:Drug Combinations; D004342:Drug Hypersensitivity / Q000209:etiology* / Q000276:immunology; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D015378:Imipenem / Q000009:adverse effects* / Q000276:immunology; D015151:Immunoblotting; D007073:Immunoglobulin E / Q000097:blood; D000077731:Meropenem; D013845:Thienamycins / Q000276:immunology / Q000627:therapeutic use*
D004338:Drug Combinations; D013845:Thienamycins; D015377:Cilastatin; D007073:Immunoglobulin E; D015378:Imipenem; D000077728:Cilastatin, Imipenem Drug Combination; D000077731:Meropenem